A global leader in in vitro diagnostics for over 55 years, bioMérieux contributes to the quality of patient care and the safety of consumers. The Company develops and produces in vitro diagnostic solutions (systems, reagents, software and services) for private and hospital laboratories, mainly for the diagnosis of infectious diseases. bioMérieux has also applied the expertise acquired in the clinical sector to meeting industrial microbiology needs, making it possible to manage contamination risks in agri-food, pharmaceutical and cosmetic products.
bioMérieux has been supporting TSE researchers since December 2020 to encourage and promote fundamental and applied research on emerging issues in the field of health economics.
Research findings wil be shared not only with the scientific community but also with a wider audience, in order to raise awareness on these topical issues in the field of health economics.
Researchers focus on two main topics which are of common interest to bioMérieux and TSE:
- Antimicrobial resistance and the market failure for innovation in antibiotics and healthcare products
- Economic evaluation of innovation in diagnoses and the value of diagnostic